Communicable Diseases: New and Old Therapies and Preventive Strategies, 2nd Edition
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 26 February 2026 | Viewed by 17
Special Issue Editors
Interests: population health management; vaccination; vaccine hesitancy; health behavior and vaccination; health communication in vaccination campaigns
Special Issues, Collections and Topics in MDPI journals
Interests: vaccination; infectious disease; public health
Special Issues, Collections and Topics in MDPI journals
Interests: vaccination; infectious disease; public health
Special Issues, Collections and Topics in MDPI journals
Interests: vaccination; infectious disease; public health
Special Issues, Collections and Topics in MDPI journals
Interests: vaccine; hesitancy; public health; systematic reviews; meta-analysis; epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The emergence of new pathogens requires the ongoing development of preventive and therapeutic strategies. Additionally, the increasing concern surrounding antimicrobial resistance necessitates innovative methods and tools to combat the spread of established pathogens. We invite contributions to this Special Issue, which aims at publishing articles focused on new preventive strategies and therapies while discussing the challenges and benefits of existing approaches. We welcome original research articles, commentaries, research protocols, and reviews. Research topics may include the development of new vaccines or therapies, the efficacy of novel preventive strategies, and the current gaps in available therapies and preventive measures.
Dr. Cristina Genovese
Dr. Calimeri Sebastiano
Dr. Daniela Lo Giudice
Dr. Vincenza La Fauci
Dr. Vincenza Gianfredi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- therapies
- communicable diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
